Published in N Engl J Med on May 09, 1991
Phenotype and course of Hutchinson-Gilford progeria syndrome. N Engl J Med (2008) 5.34
Dent Disease with mutations in OCRL1. Am J Hum Genet (2004) 1.81
Lowe syndrome. Orphanet J Rare Dis (2006) 1.43
CTNS mutations in an American-based population of cystinosis patients. Am J Hum Genet (1998) 1.41
Renal phenotype in Lowe Syndrome: a selective proximal tubular dysfunction. Clin J Am Soc Nephrol (2008) 1.24
Inherited cerebrorenal syndromes. Nat Rev Nephrol (2009) 1.00
Increased levels of plasma lysosomal enzymes in patients with Lowe syndrome. Proc Natl Acad Sci U S A (1999) 0.99
Mouse model for Lowe syndrome/Dent Disease 2 renal tubulopathy. J Am Soc Nephrol (2010) 0.93
L-Carnitine. Arch Dis Child (1996) 0.89
The promoter of a lysosomal membrane transporter gene, CTNS, binds Sp-1, shares sequences with the promoter of an adjacent gene, CARKL, and causes cystinosis if mutated in a critical region. Am J Hum Genet (2001) 0.86
Species-specific difference in expression and splice-site choice in Inpp5b, an inositol polyphosphate 5-phosphatase paralogous to the enzyme deficient in Lowe Syndrome. Mamm Genome (2010) 0.84
Lowe syndrome: a single center's experience in Korea. Korean J Pediatr (2014) 0.83
Cystinosis: renal glomerular and renal tubular function in relation to compliance with cystine-depleting therapy. Pediatr Nephrol (2014) 0.82
The oculocerebrorenal syndrome of Lowe: an update. Pediatr Nephrol (2016) 0.82
A novel pathogenic DNA variation in the OCRL1 gene in Lowe syndrome. J Clin Res Pediatr Endocrinol (2011) 0.82
Clinical and laboratory features of Macedonian children with OCRL mutations. Pediatr Nephrol (2011) 0.78
Postoperative adverse outcomes in intellectually disabled surgical patients: a nationwide population-based study. PLoS One (2011) 0.77
Muscle involvement in Dent disease 2. Pediatr Nephrol (2014) 0.76
Kidney Tubular Ablation of Ocrl/Inpp5b Phenocopies Lowe Syndrome Tubulopathy. J Am Soc Nephrol (2016) 0.75
Hydrochlorothiazide reduces urinary calcium excretion in a child with Lowe syndrome. Clin Kidney J (2015) 0.75
The 5-phosphatase OCRL in Lowe syndrome and Dent disease 2. Nat Rev Nephrol (2017) 0.75
Anesthetic management for a patient with oculocerebrorenal (Lowe's) syndrome. J Anesth (1994) 0.75
Altered trafficking of lysosomal proteins in Hermansky-Pudlak syndrome due to mutations in the beta 3A subunit of the AP-3 adaptor. Mol Cell (1999) 4.67
Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Association. JAMA (1999) 3.11
Cystine transport is defective in isolated leukocyte lysosomes from patients with cystinosis. Science (1982) 2.49
Genetic defects and clinical characteristics of patients with a form of oculocutaneous albinism (Hermansky-Pudlak syndrome). N Engl J Med (1998) 2.42
Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation (1997) 2.32
Occipital horn syndrome and a mild Menkes phenotype associated with splice site mutations at the MNK locus. Nat Genet (1994) 2.25
Cardiovascular features of homozygous familial hypercholesterolemia: analysis of 16 patients. Am J Cardiol (1984) 1.99
Improved renal function in children with cystinosis treated with cysteamine. N Engl J Med (1993) 1.98
Defective cystine exodus from isolated lysosome-rich fractions of cystinotic leucocytes. J Biol Chem (1982) 1.94
Cysteamine therapy for children with nephropathic cystinosis. N Engl J Med (1987) 1.92
Clinical, molecular, and cell biological aspects of Chediak-Higashi syndrome. Mol Genet Metab (1999) 1.91
Pulmonary function and high-resolution CT findings in patients with an inherited form of pulmonary fibrosis, Hermansky-Pudlak syndrome, due to mutations in HPS-1. Chest (2000) 1.90
Mutation of a new gene causes a unique form of Hermansky-Pudlak syndrome in a genetic isolate of central Puerto Rico. Nat Genet (2001) 1.83
Early copper therapy in classic Menkes disease patients with a novel splicing mutation. Ann Neurol (1995) 1.82
Increased formation of distinct F2 isoprostanes in hypercholesterolemia. Circulation (1999) 1.79
The α-granule proteome: novel proteins in normal and ghost granules in gray platelet syndrome. J Thromb Haemost (2010) 1.73
Clinical biochemical and pathologic correlations in Bietti's crystalline dystrophy. Am J Ophthalmol (1994) 1.70
Quantitation of plasma apolipoproteins in the primary and secondary prevention of coronary artery disease. Ann Intern Med (1994) 1.70
Molecular cloning and characterization of rab27a and rab27b, novel human rab proteins shared by melanocytes and platelets. Biochem Mol Med (1997) 1.63
Classic nephropathic cystinosis as an adult disease. JAMA (1993) 1.62
A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication. Mol Psychiatry (2010) 1.61
AP-3 mediates tyrosinase but not TRP-1 trafficking in human melanocytes. Mol Biol Cell (2001) 1.60
Type III 3-methylglutaconic aciduria (optic atrophy plus syndrome, or Costeff optic atrophy syndrome): identification of the OPA3 gene and its founder mutation in Iraqi Jews. Am J Hum Genet (2001) 1.56
Zidovudine-induced mitochondrial myopathy is associated with muscle carnitine deficiency and lipid storage. Ann Neurol (1994) 1.55
Molecular characterization of the protein encoded by the Hermansky-Pudlak syndrome type 1 gene. J Biol Chem (2000) 1.51
Mutations in 3 genes (MKS3, CC2D2A and RPGRIP1L) cause COACH syndrome (Joubert syndrome with congenital hepatic fibrosis). J Med Genet (2009) 1.50
Elevated plasma lipoprotein(a) in patients with the nephrotic syndrome. Ann Intern Med (1993) 1.50
Indian childhood cirrhosis in an American child. Gastroenterology (1992) 1.47
The metabolism of fatty acids in human Bietti crystalline dystrophy. Invest Ophthalmol Vis Sci (2001) 1.46
CTNS mutations in an American-based population of cystinosis patients. Am J Hum Genet (1998) 1.41
Defective sialic acid egress from isolated fibroblast lysosomes of patients with Salla disease. Science (1986) 1.41
Effect of growth hormone treatment on serum creatinine concentration in patients with cystinosis and chronic renal disease. J Pediatr (1992) 1.40
Characteristics of cystine counter-transport in normal and cystinotic lysosome-rich leucocyte granular fractions. Biochem J (1983) 1.40
Hermansky-Pudlak syndrome and related disorders of organelle formation. Traffic (2000) 1.40
Proteomic analysis of platelet alpha-granules using mass spectrometry. J Thromb Haemost (2007) 1.40
NTBC and alkaptonuria. Am J Hum Genet (1998) 1.38
The role of nitric oxide in endothelium-dependent vasodilation of hypercholesterolemic patients. Circulation (1993) 1.36
Cumulative effects of high cholesterol levels, high blood pressure, and cigarette smoking on carotid stenosis. N Engl J Med (1997) 1.33
The genomic region encompassing the nephropathic cystinosis gene (CTNS): complete sequencing of a 200-kb segment and discovery of a novel gene within the common cystinosis-causing deletion. Genome Res (2000) 1.32
Plasma and cerebrospinal fluid neurochemical pattern in Menkes disease. Ann Neurol (1993) 1.32
Hermansky-Pudlak syndrome type 3 in Ashkenazi Jews and other non-Puerto Rican patients with hypopigmentation and platelet storage-pool deficiency. Am J Hum Genet (2001) 1.28
A new variant of Hermansky-Pudlak syndrome due to mutations in a gene responsible for vesicle formation. Am J Med (2000) 1.27
Patterns of amino acid efflux from isolated normal and cystinotic human leucocyte lysosomes. J Biol Chem (1982) 1.25
Effects of early cysteamine therapy on thyroid function and growth in nephropathic cystinosis. J Clin Endocrinol Metab (1995) 1.24
Filipin as a flow microfluorometry probe for cellular cholesterol. Cytometry (1984) 1.23
The association of LDL receptor activity, LDL cholesterol level, and clinical course in homozygous familial hypercholesterolemia. Metabolism (1985) 1.23
Cystine accumulation and clearance by normal and cystinotic leukocytes exposed to cystine dimethyl ester. Proc Natl Acad Sci U S A (1982) 1.21
Identification and detection of the common 65-kb deletion breakpoint in the nephropathic cystinosis gene (CTNS). Mol Genet Metab (1999) 1.21
Successful early copper therapy in Menkes disease associated with a mutant transcript containing a small In-frame deletion. Biochem Mol Med (1996) 1.20
The method of determination must be considered in interpreting blood cholesterol levels. JAMA (1986) 1.20
Hermansky-Pudlak syndrome: models for intracellular vesicle formation. Mol Genet Metab (1998) 1.20
Characterization of hepatic low density lipoprotein binding and cholesterol metabolism in normal and homozygous familial hypercholesterolemic subjects. J Clin Invest (1984) 1.18
Mutations in the human UDP-N-acetylglucosamine 2-epimerase gene define the disease sialuria and the allosteric site of the enzyme. Am J Hum Genet (1999) 1.16
Cholesteryl ester storage disease and Wolman disease: phenotypic variants of lysosomal acid cholesteryl ester hydrolase deficiency. Am J Hum Genet (1984) 1.15
A comparison of the effectiveness of cysteamine and phosphocysteamine in elevating plasma cysteamine concentration and decreasing leukocyte free cystine in nephropathic cystinosis. Pediatr Res (1988) 1.14
Disorders of vesicles of lysosomal lineage: the Hermansky-Pudlak syndromes. Curr Mol Med (2002) 1.14
Analysis of the apolipoprotein B gene and messenger ribonucleic acid in abetalipoproteinemia. J Clin Invest (1986) 1.13
Transsulfuration in an adult with hepatic methionine adenosyltransferase deficiency. J Clin Invest (1988) 1.11
Mutations in the glutathione synthetase gene cause 5-oxoprolinuria. Nat Genet (1996) 1.10
Molecular cloning and characterization of human VPS18, VPS 11, VPS16, and VPS33. Gene (2001) 1.10
Defective lysosomal egress of free sialic acid (N-acetylneuraminic acid) in fibroblasts of patients with infantile free sialic acid storage disease. J Biol Chem (1989) 1.10
Transamination of methionine in humans. Clin Sci (Lond) (1989) 1.10
CTNS mutations in patients with cystinosis. Hum Mutat (1999) 1.09
Long-term ocular manifestations in nephropathic cystinosis. Arch Ophthalmol (1986) 1.09
Cysteamine depletes cystinotic leucocyte granular fractions of cystine by the mechanism of disulphide interchange. Biochem J (1985) 1.08
Ocular nonnephropathic cystinosis: clinical, biochemical, and molecular correlations. Pediatr Res (2000) 1.07
Plasma amino acids in appropriate- and small-for-gestational-age fetuses. Am J Obstet Gynecol (1989) 1.07
Altered protein localization in melanocytes from Hermansky-Pudlak syndrome: support for the role of the HPS gene product in intracellular trafficking. Lab Invest (1998) 1.07
Lysosomal cystine counter-transport in heterozygotes for cystinosis. Am J Hum Genet (1984) 1.07
The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humans. J Clin Invest (1995) 1.07
Baseline elevated leukocyte count in peripheral blood is associated with poor survival in patients with advanced non-small cell lung cancer: a prognostic model. J Cancer Res Clin Oncol (2008) 1.07
Levels of lipoprotein Lp(a) decline with neomycin and niacin treatment. Atherosclerosis (1985) 1.05
Distal vacuolar myopathy in nephropathic cystinosis. Ann Neurol (1994) 1.04
Blunted prolactin response to thyrotropin-releasing hormone stimulation in cystinotic children receiving cysteamine. J Clin Endocrinol Metab (1985) 1.04
Evaluation of the aortic root by MRI: insights from patients with homozygous familial hypercholesterolemia. Circulation (1998) 1.04
Recent advances in the treatment of cystinosis. J Inherit Metab Dis (1995) 1.04
Course of nephropathic cystinosis after age 10 years. J Pediatr (1986) 1.04
Cultured human hepatocytes. Evidence for metabolism of low density lipoproteins by a pathway independent of the classical low density lipoprotein receptor. J Biol Chem (1986) 1.03
Abnormal synthesis of dolichol-linked oligosaccharides in carbohydrate-deficient glycoprotein syndrome. Glycobiology (1995) 1.03
A randomized clinical trial of topical cysteamine disulfide (cystamine) versus free thiol (cysteamine) in the treatment of corneal cystine crystals in cystinosis. Mol Genet Metab (1998) 1.02
Sialic acid metabolism in sialuria fibroblasts. J Biol Chem (1991) 1.02
Cystinosis coming of age. Adv Pediatr (1986) 1.02
Distinct hepatic receptors for low density lipoprotein and apolipoprotein E in humans. Science (1985) 1.01
Predictive value of plasma catecholamine levels in neonatal detection of Menkes disease. J Inherit Metab Dis (1993) 1.01
Removal of corneal crystals by topical cysteamine in nephropathic cystinosis. N Engl J Med (1987) 1.00
Determinants of coronary artery calcification progression in renal transplant recipients. Am J Transplant (2007) 1.00
Neurologic complications in long-standing nephropathic cystinosis. Arch Neurol (1989) 1.00
Heterozygote detection in cystinosis, using leukocytes exposed to cystine dimethyl ester. N Engl J Med (1982) 0.99
Plasma and muscle free carnitine deficiency due to renal Fanconi syndrome. J Clin Invest (1985) 0.99
Intracellular distribution of lysosomal sialidase is controlled by the internalization signal in its cytoplasmic tail. J Biol Chem (2001) 0.99
Polyamine degradation in foetal and adult bovine serum. Biochem J (1982) 0.99